In this episode, Douglas Heintzman, Chief Catalyst at the Blockchain Research Institute, and Ray Dogum meet to uncover the cutting-edge intersection of AI, blockchain, and personalized medicine in healthcare. With extensive experience at IBM, Doug provides profound insights into AI's transformative role in drug discovery, clinical trials, diagnostics, and mental health therapy. The episodes explore the potentials and challenges of decentralized clinical trials, consent management, and combating drug counterfeiting with blockchain. They also discuss the rise of AI personal health assistants, the ethical implications of AI in healthcare, and the innovative field of electroceuticals. Discover the future of healthcare through the lens of technological convergence, aiming for personalized and efficient medical care.
This conversation was first featured on W3B Talks earlier in February of 2024.
00:00 Introduction
02:15 Diving into AI and Healthcare
04:41 Personalized Medicine and AI
09:23 Challenges in Clinical Trials
18:36 Supply Chain Management in Healthcare
21:04 Blockchain and Drug Counterfeiting
26:16 AI Therapists and Personal Assistants
30:19 Limitations and Ethical Concerns of AI
36:05 Global Datasets and Training AI Models
39:35 Challenges in Healthcare Data Segmentation
45:31 Decentralizing Scientific Research
51:16 AI's Role in Peer Review and Research Integrity
55:07 AI in Primary Healthcare and Ethical Considerations
01:03:59 Predictions for the Next Decade in Healthcare
01:05:32 Outro